Seniors with diabetes and dementia more likely to fall into Medicare Part D prescription drug plan

Researchers recommend doctor-patient counseling to manage drug regimens

Among seniors, women and patients with diabetes and dementia are the most likely to fall into the Medicare Part D prescription drug plan "donut hole" - the gap occurring after beneficiaries reach their annual coverage limit and before catastrophic coverage kicks in - according to new research published online in the Journal of General Internal Medicine.

Because this gap leaves them exposed to unsubsidized medication costs, these clinically vulnerable groups should be counseled on how to best manage costs through either drug substitution or discontinuation of specific non-essential medications, according to Susan Ettner, professor of medicine in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA and the study's lead author.

"This is important so that more essential medication is not discontinued, with adverse effects on patients' health due to cost reasons only," she said. "These patients need to continue adhering to their medication regimen."

As an example, an average 67-year-old woman with diabetes and a typical set of "co-morbidities" - hypertension, hyperlipidemia, coronary artery disease and depression - would have a 54-percent chance of falling into the coverage gap and being exposed to the full cost of her medication. If she fell into the gap, she would have an 11-percent chance of exiting again, but in the meantime, she would have incurred more than $3,600 in total out-of-pocket drug expenses.

"Our findings suggest that medication cost-counseling interventions focusing on these clinically vulnerable subpopulations may be warranted," the authors conclude. "Physician-patient discussions about the expense and undesirable side effects of particular medications are one approach to managing outpatient drug therapy and controlling costs."

In 2006, 3.4 million seniors purchased a Part D plan, which provides prescription drug coverage to all Medicare beneficiaries. The plan was expected to improve adherence to drug regimens and health outcomes through improved financial access to medications. However, the standard Part D benefit includes a coverage gap, the so-called donut hole. After a Medicare beneficiary surpasses the prescription drug coverage limit for the year, he or she becomes financially responsible for the entire cost of prescription drugs until the expense reaches another threshold - the catastrophic coverage threshold.

Looking at records from more than 287,000 Medicare recipients in eight U.S. states, primarily in the West, Ettner and her team investigated which beneficiaries were most likely to fall into the gap, as well as which medical conditions could put them there. They also examined which medications contributed most to pre-gap spending.

They found that 16 percent of enrollees entered the gap, with nearly 3 percent entering the gap very early, within the first 180 days of the year. Of those who entered the gap, only 7 percent exited again. Women and patients with dementia and diabetes were the most likely to enter the gap. Other conditions also predisposed beneficiaries to gap entry, including end-stage renal disease, coronary artery disease, chronic obstructive pulmonary disease, mental health conditions and congestive heart failure.

Source: University of California - Los Angeles

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rare variant analysis reveals genetic spectrum of monogenic diabetes genes